切换至 "中华医学电子期刊资源库"

中华普通外科学文献(电子版) ›› 2021, Vol. 15 ›› Issue (04) : 300 -301. doi: 10.3877/cma.j.issn.1674-0793.2021.04.013

病例报告

手术治疗肝癌合并门静脉主干癌栓(程氏Ⅳ型)一例
印宗毅1, 刘辉1, 田佩凯1, 彭敏劼1, 李晓武1,()   
  1. 1. 518035 深圳大学总医院肝胆外科 深圳大学卡尔森国际肿瘤中心
  • 收稿日期:2020-08-03 出版日期:2021-08-03
  • 通信作者: 李晓武

Management of hepatocellular carcinoma and portal vein tumour thrombosis (Cheng’s Classification Type Ⅳ): A case report

Zongyi Yin1, Hui Liu1, Peikai Tian1   

  • Received:2020-08-03 Published:2021-08-03
引用本文:

印宗毅, 刘辉, 田佩凯, 彭敏劼, 李晓武. 手术治疗肝癌合并门静脉主干癌栓(程氏Ⅳ型)一例[J]. 中华普通外科学文献(电子版), 2021, 15(04): 300-301.

Zongyi Yin, Hui Liu, Peikai Tian. Management of hepatocellular carcinoma and portal vein tumour thrombosis (Cheng’s Classification Type Ⅳ): A case report[J]. Chinese Archives of General Surgery(Electronic Edition), 2021, 15(04): 300-301.

图1 术前CT显示右肝巨大肝占位和门脉主干及肠系膜上癌栓形成 A为平扫期;B为增强期;C、D为门静脉期;E为延迟期;F为三维重建
图2 术后10个月复查可见肝内无新发病灶形成和门静脉癌栓 A为MRI结果;B为CT结果
[1]
Lu J, Zhang XP, Zhong BY, et al. Management of patients with hepatocellular carcinoma and portal vein tumour thrombosis: comparing east and west[J]. Lancet Gastroenterol Hepatol, 2019, 4(9): 721-730.
[2]
Basit SA, Stone CD, Gish R. Portal vein thrombosis[J]. Clin Liver Dis, 2015, 19(1): 199-221.
[3]
Chan SL, Chong CC, Chan AW, et al. Management of hepatocellular carcinoma with portal vein tumor thrombosis: review and update at 2016[J]. World J Gastroenterol, 2016, 22(32): 7289-7300.
[4]
Gao Y, Wang PX, Cheng JW, et al. Chemotherapeutic perfusion of portal vein after tumor thrombectomy and hepatectomy benefits patients with advanced hepatocellular carcinoma: A propensity score-matched survival analysis[J]. Cancer Med, 2019, 8(16): 6933-6944.
[5]
Liu PH, Huo TI, Miksad RA. Hepatocellular carcinoma with portal vein tumor involvement: best management strategies[J]. Semin Liver Dis, 2018, 38(3): 242-251.
[6]
中华人民共和国国家卫生健康委员会医政医管局. 原发性肝癌诊疗规范(2019年版)[J]. 中华消化外科杂志, 2020, 19(1): 1-20.
[7]
Intagliata NM, Caldwell SH, Tripodi A. Diagnosis, development, and treatment of portal vein thrombosis in patients with and without cirrhosis[J]. Gastroenterology, 2019, 156(6): 1582-1599, e1.
[8]
Borsig L. Heparin as an inhibitor of cancer progression[J]. Prog Mol Biol Transl Sci, 2010, 93: 335-349.
[9]
Linhardt RJ. Heparin-induced cancer cell death[J]. Chem Biol, 2004, 11(4): 420-422.
[10]
程树群,吴孟超,陈汉, 等. 胸腺肽α1对原发性肝癌术后复发的影响[J]. 中华肝胆外科杂志, 2004, 10(9): 592-593.
No related articles found!
阅读次数
全文


摘要